Skip to main content
. 2020 Nov 6;99(45):e21563. doi: 10.1097/MD.0000000000021563

Table 4.

Subgroup analyses on study eye sizes.

Eye sizes (≧100 versus < 100) Studies Eyes OR or MD (95%CI) P I2
Postoperative UCVA of 20/20 or better 8 1397 OR 1.09 (0.62, 1.92) .763 0.0%
≧100 4 1090 OR 1.16 (0.55, 2.44) .697 0.0%
<100 4 307 OR 1.00 (0.42, 2.38) .991 0.0%
Postoperative UCVA 7 1645 MD 0.04 (0.01, 0.07) .012 76.9%
≧100 5 1543 MD 0.05 (0.01, 0.08) .006 82.8%
<100 2 102 MD −0.01 (−0.09, 0.07) .839 0.0%
Preoperative Q-value 11 1605 MD −0.00 (−0.02, 0.02) .922 68.0%
≧100 6 1242 MD −0.01 (−0.03, 0.02) .678 82.9%
<100 5 363 MD 0.01 (−0.02, 0.03) .547 0.0%
Postoperative Q-value 11 1655 MD −0.42 (−0.64, −0.21) .000 98.4%
≧100 6 1292 MD −0.46 (−0.73, −0.18) .001 98.9%
<100 5 363 MD −0.38 (−0.83, 0.06) .093 97.9%
Postoperative refractive SE 6 1627 MD 0.08 (−0.09, 0.25) .336 95.4%
≧100 5 1543 MD 0.11 (−0.11, 0.33) .315 96.3%
<100 1 84 MD −0.02 (−0.10, 0.06) .621 /
HOA 10 1309 MD −0.14 (−0.23, −0.06) .001 98.5%
≧100 3 813 MD −0.18 (−0.40, 0.04) .109 99.6%
<100 7 496 MD −0.12 (−0.20, −0.05) .001 94.6%
Horizontal coma-like aberration 5 404 MD −0.00 (−0.03, 0.03) .966 0.0%
≧100 1 128 MD 0.00 (−0.05, 0.06) .880 /
<100 4 276 MD −0.00 (−0.05, 0.04) .851 0.0%
Vertical coma-like aberration 6 455 MD −0.01 (−0.03, 0.01) .263 0.0%
≧100 1 128 MD −0.00 (−0.05, 0.04) .814 /
<100 5 327 MD −0.01 (−0.04, 0.01) .253 0.0%
Spherical-like aberration 12 1305 MD −0.19 (−0.32, −0.06) .004 99.2%
≧100 5 809 MD −0.36 (−0.64, −0.08) .011 99.6%
<100 7 496 MD −0.08 (−0.20, 0.05) .238 98.6%